Biofilm microenvironment-responsive nanoparticles for the treatment of bacterial infection

Y Hu, X Ruan, X Lv, Y Xu, W Wang, Y Cai, M Ding… - Nano Today, 2022 - Elsevier
Highlights•The biofilm formation process and its microenvironmental characteristics are
described.•Biofilm microenvironment-responsive nanoparticles for anti-infection are …

Advances in nanotechnology for biofilm inhibition

L Kumar, M Bisen, K Harjai, S Chhibber, S Azizov… - ACS …, 2023 - ACS Publications
Biofilm-associated infections have emerged as a significant public health challenge due to
their persistent nature and increased resistance to conventional treatment methods. The …

Antibiotic resistance in patients with cystic fibrosis: past, present, and future

EP Perikleous, D Gkentzi, A Bertzouanis, E Paraskakis… - Antibiotics, 2023 - mdpi.com
Patients with cystic fibrosis (CF) are repeatedly exposed to antibiotics, especially during the
pulmonary exacerbations of the disease. However, the available therapeutic strategies are …

An update of mobile colistin resistance in non-fermentative gram-negative bacilli

P Khuntayaporn, K Thirapanmethee… - Frontiers in Cellular …, 2022 - frontiersin.org
Colistin, the last resort for multidrug and extensively drug-resistant bacterial infection
treatment, was reintroduced after being avoided in clinical settings from the 1970s to the …

Antimicrobial Resistance, Genetic Lineages, and Biofilm Formation in Pseudomonas aeruginosa Isolated from Human Infections: An Emerging One Health Concern

A Silva, V Silva, M López, B Rojo-Bezares, JA Carvalho… - Antibiotics, 2023 - mdpi.com
Pseudomonas aeruginosa (PA) is a leading nosocomial pathogen and has great versatility
due to a complex interplay between antimicrobial resistance and virulence factors. PA has …

Pseudomonas aeruginosa transcriptome analysis of metal restriction in ex vivo cystic fibrosis sputum

SL Neff, G Doing, T Reiter, TH Hampton… - Microbiology …, 2024 - Am Soc Microbiol
Chronic Pseudomonas aeruginosa lung infections are a feature of cystic fibrosis (CF) that
many patients experience even with the advent of highly effective modulator therapies …

Uncovering the NAFLD burden in people living with HIV from high‐and middle‐income nations: a meta‐analysis with a data gap from Subsaharan Africa

R Manzano‐Nunez, J Rivera‐Esteban… - African Journal of …, 2023 - journals.lww.com
Uncovering the NAFLD burden in people living with HIV from h... : African Journal of
Reproduction and Gynaecological Endoscopy Uncovering the NAFLD burden in people living …

Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development

SL Neff, TH Hampton, K Koeppen, S Sarkar… - Msystems, 2023 - Am Soc Microbiol
Developing software tools that leverage biological data sets to accelerate drug discovery is
an important aspect of bioinformatic research. Here, we present a novel example: a web …

The Impact of Antimicrobial Resistance in cystic fibrosis

A Vitiello, F Blasi, M Sabbatucci, A Zovi, F Miele… - Journal of Clinical …, 2024 - mdpi.com
The phenomenon of antimicrobial resistance (AMR) is a critical global health challenge, with
prospects indicating its potential to become the leading cause of death worldwide in the …

Flowering phenophases influence the antibacterial and anti-biofilm effects of Thymus vulgaris L. essential oil

C Bakó, VL Balázs, E Kerekes, B Kocsis… - … Medicine and Therapies, 2023 - Springer
Background Essential oils are becoming increasingly popular in medicinal applications
because of their antimicrobial effect. Thymus vulgaris L.(Lamiaceae) is a well-known and …